Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1376609 | 0.89 | SCD (0.60) | SCDDCTPP1 | |
| SCHEMBL27722157 | 0.89 | SCD (0.60) | SCDDCTPP1 | |
| SCHEMBL27701504 | 0.85 | SCD (0.61) | SCDDCTPP1 | |
| SCHEMBL937193 | 0.85 | SCD (0.71) | SCDDCTPP1 | |
| SCHEMBL1376810 | 0.84 | SCD (1.00) | SCDDCTPP1 | |
| SCHEMBL1381079 | 0.83 | SCD (1.00) | SCDDCTPP1 | |
| SCHEMBL1380561 | 0.83 | SCD (1.00) | SCDDCTPP1 | |
| SCHEMBL27654402 | 0.83 | SCD (0.71) | SCDDCTPP1 | |
| SCHEMBL938162 | 0.82 | SCD (0.62) | SCDDCTPP1 | |
| SCHEMBL27633597 | 0.82 | SCD (0.69) | SCDDCTPP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101203244-A | Compositions of rennin inhibitor and insulin secernent or insulin sensitizer | NOVARTIS AG (CH) | 2008-06-18 | — | — | CN | claimed |
| CN-101163504-A | Combination therapy | XENON PHARMACEUTICALS INC (CA) | 2008-04-16 | — | — | CN | claimed |
| CN-101203244-A | Compositions of rennin inhibitor and insulin secernent or insulin sensitizer | NOVARTIS AG (CH) | 2008-06-18 | — | — | CN | disclosed |
| CN-101163504-A | Combination therapy | XENON PHARMACEUTICALS INC (CA) | 2008-04-16 | — | — | CN | disclosed |